At the European Society for Medical Oncology (ESMO) 2014 Congress, Prof Charles Swanton (London Research Institute and University College London, UK) discusses the importance of understanding the genetic changes of tumour evolution for the development of more effective management options that are tailored to individual genetic profiles this is termed precision medicine.